Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3087004
Max Phase: Preclinical
Molecular Formula: C42H63N7O5
Molecular Weight: 746.01
Molecule Type: Small molecule
Associated Items:
ID: ALA3087004
Max Phase: Preclinical
Molecular Formula: C42H63N7O5
Molecular Weight: 746.01
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCC(=O)N[C@H](/C=C/C(=O)N[C@@H](CCCCN)C(=O)N[C@H](/C=C/C(=O)N[C@@H](CCCCN)C(N)=O)Cc1ccccc1)Cc1ccccc1
Standard InChI: InChI=1S/C42H63N7O5/c1-2-3-4-5-12-23-38(50)46-34(30-32-17-8-6-9-18-32)24-26-40(52)49-37(22-14-16-29-44)42(54)47-35(31-33-19-10-7-11-20-33)25-27-39(51)48-36(41(45)53)21-13-15-28-43/h6-11,17-20,24-27,34-37H,2-5,12-16,21-23,28-31,43-44H2,1H3,(H2,45,53)(H,46,50)(H,47,54)(H,48,51)(H,49,52)/b26-24+,27-25+/t34-,35-,36+,37+/m1/s1
Standard InChI Key: AEHDVVBWBPSJPE-BABOUGLMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 746.01 | Molecular Weight (Monoisotopic): 745.4891 | AlogP: 3.63 | #Rotatable Bonds: 28 |
Polar Surface Area: 211.53 | Molecular Species: BASE | HBA: 7 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 13.13 | CX Basic pKa: 10.51 | CX LogP: 3.85 | CX LogD: -1.36 |
Aromatic Rings: 2 | Heavy Atoms: 54 | QED Weighted: 0.05 | Np Likeness Score: 0.19 |
1. Shankar SS, Benke SN, Nagendra N, Srivastava PL, Thulasiram HV, Gopi HN.. (2013) Self-assembly to function: design, synthesis, and broad spectrum antimicrobial properties of short hybrid E-vinylogous lipopeptides., 56 (21): [PMID:24117107] [10.1021/jm400884w] |
Source(1):